Quick Answer
Summit Therapeutics Inc. reported Net Income of -$1.08 billion for fiscal year 2025.
Summit Therapeutics Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$1.08B | -387.8% |
| 2024 | -$221.31M | +64.0% |
| 2023 | -$614.93M | -680.5% |
| 2022 | -$78.78M | +11.1% |
| 2021 | -$88.60M | -68.1% |
| 2020 | -$52.70M | -80.9% |
| 2019 | -$29.13M | -368.0% |
| 2019 | $10.87M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$231.79M | -312.0% | +59.0% |
| June 30, 2025 | -$565.71M | -836.8% | -799.2% |
| March 31, 2025 | -$62.91M | -44.7% | -11.8% |
| September 30, 2024 | -$56.25M | -164.5% | +6.8% |
| June 30, 2024 | -$60.38M | -310.3% | -38.9% |
| March 31, 2024 | -$43.47M | +92.0% | -104.4% |
| September 30, 2023 | -$21.27M | +0.5% | -44.5% |
| June 30, 2023 | -$14.72M | +12.2% | +97.3% |
- Summit Therapeutics Inc. showed a decrease of -387.8% in Net Income compared to the prior fiscal year.
- Over the 2019–2025 period, Summit Therapeutics Inc.’s net income has declined by 10032.7% (from $10.87 million to -$1.08 billion).
- The most recent figure is from Summit Therapeutics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: